Overview
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.
Indication
For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.
Associated Conditions
- Hyperthyroidism
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2017/02/27 | N/A | Completed | Clinical Nutrition Research Centre, Singapore | ||
2011/09/20 | Phase 3 | Completed | Newcastle-upon-Tyne Hospitals NHS Trust |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| CARBIMAZOLE 5 TABLET 5 mg | SIN06923P | TABLET, FILM COATED | 5 mg | 3/23/1992 | |
| CARBIMAZOLE TABLET 5 mg | SIN04453P | TABLET | 5 mg | 5/22/1990 | |
| CAMAZOL TABLET 5 mg | SIN04490P | TABLET | 5 mg | 5/22/1990 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| NOVAMAZE carbimazole 5 mg tablet bottle | 397412 | Medicine | A | 8/17/2023 | |
| SPPL CARBIMAZOLE 5 carbimazole 5 mg tablet blister pack | 349091 | Medicine | A | 9/9/2022 | |
| WP CARBIMAZOLE 20 carbimazole 20 mg tablet blister pack | 349096 | Medicine | A | 9/9/2022 | |
| SPPL CARBIMAZOLE 20 carbimazole 20 mg tablet blister pack | 349093 | Medicine | A | 9/9/2022 | |
| SP CARBIMAZOLE 5 carbimazole 5 mg tablet blister pack | 349090 | Medicine | A | 9/9/2022 | |
| NEO-MERCAZOLE carbimazole 5 mg tablet bottle | 194296 | Medicine | A | 5/23/2012 | |
| THIRAZOL carbimazole 5 mg tablet bottle | 397413 | Medicine | A | 8/17/2023 | |
| SP CARBIMAZOLE 20 carbimazole 20 mg tablet blister pack | 349094 | Medicine | A | 9/9/2022 | |
| WP CARBIMAZOLE 5 carbimazole 5 mg tablet blister pack | 349095 | Medicine | A | 11/26/2021 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| NEO-TOMIZOL 5 mg COMPRIMIDOS | 28996 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.